PYCARD and breast cancer: Clinical analysis revealed that NLRP3 and PYCARD expression was strongly associated with the presence of several more aggressive clinicopathological factors, such as tumor size, histological grade and Ki67 index and pointed to the contribution of both proteins to BC progression via their relationship with the expression of receptors and factors closely associated with tumor growth.